Pictet-Biotech HP CHF

Register to Unlock Ratings
Performance History31/07/2024
Growth of 1,000 (GBP) Advanced Graph
Pictet-Biotech HP CHF
Fund33.2-11.7-9.312.72.4
+/-Cat-----
+/-B’mrk-----
 
Key Stats
NAV
14/08/2024
 CHF 688.31
Day Change -0.28%
Morningstar Category™ Other Equity
ISIN LU0843168732
Fund Size (Mil)
14/08/2024
 USD 1627.04
Share Class Size (Mil)
14/08/2024
 CHF 11.01
Max Initial Charge 5.00%
Ongoing Charge
14/02/2024
  2.04%
Investment Objective: Pictet-Biotech HP CHF
To increase the value of your investment while seeking to achieve a positive social impact. The Fund applies a sustainable strategy and invests at least two-thirds of its net assets in equities or similar securities issued by biopharmaceutical companies throughout the world. Companies supporting the health of people with high innovation capacity. Better therapies can deliver true value to patients and healthcare systems alike. These companies are tackling high unmet medical needs and reduce the pressures on healthcare budgets through the reduction of hospital admissions or symptom management. The Fund invests mainly in companies whose significant proportion of their activities are related to, but not limited to, new mechanisms of actions offering potential cures or management of diseases that were hard to treat before, technology platforms, research tools and services in the biotechnology value chain as well as the improvement of therapies or drugs.
Returns
Trailing Returns (GBP)14/08/2024
YTD1.68
3 Years Annualised0.68
5 Years Annualised4.82
10 Years Annualised5.63
12 Month Yield 0.00
Management
Manager Name
Start Date
Tazio Storni
26/05/2016
Marco Minonne
01/06/2020
Click here to see others
Inception Date
23/10/2012
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
MSCI ACWI NR EUR-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Pictet-Biotech HP CHF31/07/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock98.670.0098.67
Bond0.040.000.04
Property0.000.000.00
Cash1.690.391.30
Other0.000.000.00
Top 5 Regions%
United States91.13
Europe - ex Euro4.29
Eurozone2.89
Canada1.70
Latin America0.00
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Regeneron Pharmaceuticals IncHealthcareHealthcare5.11
argenx SE ADRHealthcareHealthcare5.11
Biomarin Pharmaceutical IncHealthcareHealthcare3.93
Sarepta Therapeutics IncHealthcareHealthcare3.58
Intra-Cellular Therapies IncHealthcareHealthcare3.49
Pictet-Biotech HP CHF

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures